. Author manuscript; available in PMC: 2021 Jul 30.

Published in final edited form as: Int J Tuberc Lung Dis. 2012 Apr 9;16(7):891–896. doi: 10.5588/ijtld.11.0795

Table 3.

Drugs in baseline regimens for individuals who drank alcohol vs. those who did not during MDR-TB treatment in Tomsk, Russian Federation (N = 407)

Drug	Drinkers (n = 253) n (%)	Non-drinkers (n = 154) n (%)	P value
OFX	249 (98.4)	150 (97.4)	0.47
CS	248 (98.0)	150 (97.4)	0.68
PAS	224 (88.5)	127 (82.4)	0.09
PZA	207 (81.8)	118 (76.6)	0.21
THA	206 (81.4)	125 (81.2)	0.28
CM	157 (62.1)	84 (54.5)	0.13
KM	90 (35.6)	65 (42.2)	0.18
EMB	71 (28.1)	42 (27.3)	0.8
AMOX-CLAV	8 (3.2)	8 (5.2)	0.31
RFB	2 (0.7)	2 (1.3)	0.61
INH	2 (0.7)	4 (2.6)	0.18
MFX	1 (0.4)	2 (1.3)	0.3
AMK	0	2 (1.3)	0.07

MDR-TB = multidrug-resistant tuberculosis; OFX = ofloxacin; CS = cycloserine; PAS = para-aminosalicylic acid; PZA = pyrazinamide; THA = thiamide; CM = capreomycin; KM = kanamycin; EMB = ethambutol; AMOX-CLAV = amoxicillin-clavulanate; RFB = rifabutin; INH = isoniazid; MFX = moxifloxacin; AMK = amikacin.